Immunic
IMUX
65 hedge funds and large institutions have $51.1M invested in Immunic in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 16 reducing their positions, and 6 closing their positions.
104% more call options, than puts
Call options by funds: $859K | Put options by funds: $421K
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
25% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 16
7% more funds holding
Funds holding: 61 → 65 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.54% less ownership
Funds ownership: 6.22% → 5.67% (-0.54%)
45% less capital invested
Capital invested by funds: $92.4M → $51.1M (-$41.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$1.41M |
| 2 |
Morgan Stanley
New York
|
+$900K |
| 3 |
Millennium Management
New York
|
+$605K |
| 4 |
Renaissance Technologies
New York
|
+$224K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$217K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$5.29M |
| 2 |
Janus Henderson Group
London,
|
-$3.04M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$978K |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$377K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$302K |
IMUX Hedge Fund Activity: Q4 2024 in Review
65 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q4 2024, worth a combined $51.1M — down 45% from $92.4M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new IMUX positions and 6 closed out — a net gain of 5 holders — while 20 added to existing stakes and 16 trimmed.
The largest buyer was Ikarian Capital, adding an estimated $1.41M. The largest seller was Adage Capital Partners, cutting an estimated $5.29M.
- 65 institutional investors held Immunic (IMUX) as of Q4 2024, up from 61 in Q3 2024.
- Funds reported $51.1M of Immunic stock for Q4 2024, down 45% quarter-over-quarter.
- 11 funds opened new Immunic positions in Q4 2024 and 6 closed out, a net change of +5 holders.
- The largest Immunic buyer in Q4 2024 was Ikarian Capital, an estimated $1.41M added.
- The largest Immunic seller in Q4 2024 was Adage Capital Partners, an estimated $5.29M sold.
Based on aggregated 13F filings for Q4 2024.